Liabilities and Equity of RayzeBio, Inc. from 31 Dec 2022 to 30 Sep 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.
Summary
RayzeBio, Inc. quarterly Liabilities and Equity in USD history and change rate from 31 Dec 2022 to 30 Sep 2023.
  • RayzeBio, Inc. Liabilities and Equity for the quarter ending 30 Sep 2023 was $603,513,000.
Source SEC data
View on sec.gov
Liabilities and Equity, Quarterly (USD)

RayzeBio, Inc. Quarterly Liabilities and Equity (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2023 $603,513,000 30 Sep 2023 10-Q 13 Nov 2023 2023 Q3
Q4 2022 $324,776,000 31 Dec 2022 10-Q 13 Nov 2023 2023 Q3
* An asterisk sign (*) next to the value indicates that the value is likely invalid.